Cargando…

Short salsalate administration affects cell proliferation, metabolism, and inflammation in polycystic kidney disease

Metabolic reprogramming is a driver of autosomal dominant polycystic kidney disease (ADPKD) progression and a potential therapeutic intervention route. We showed before that the AMP-associated protein kinase (AMPK) activator salsalate attenuates cystic disease progression. Here, we aim to study the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanhai, Anish A., Sánchez-López, Elena, Kuipers, Thomas B., van Klinken, Jan B., Dijkstra, Kyra L., van der Veen, Inge, Baelde, Hans J., Song, Xuewen, Pei, York, Mei, Hailiang, Leonhard, Wouter N., Mayboroda, Oleg A., Peters, Dorien J.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665819/ https://www.ncbi.nlm.nih.gov/pubmed/38026227 http://dx.doi.org/10.1016/j.isci.2023.108278

Ejemplares similares

Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease
por: Leonhard, Wouter N., et al.
Publicado: (2019)

Preclinical evaluation of tolvaptan and salsalate combination therapy in a Pkd1-mouse model
por: Song, Xuewen, et al.
Publicado: (2023)

Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective
por: Kanhai, Anish A., et al.
Publicado: (2020)

Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
por: Dekker, Shosha E. I., et al.
Publicado: (2020)

Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression
por: Piazzon, Nathalie, et al.
Publicado: (2015)

Salsalate reduces atherosclerosis through AMPKβ1 in mice
por: Day, Emily A., et al.
Publicado: (2021)

Sheathless CE-MS based metabolic profiling of kidney tissue section samples from a mouse model of Polycystic Kidney Disease
por: Sánchez-López, Elena, et al.
Publicado: (2019)

The Effect of Salsalate Therapy on Endothelial Function in a Broad Range of Subjects
por: Nohria, Anju, et al.
Publicado: (2014)

Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
por: Wang, Xi, et al.
Publicado: (2014)

Effects of Salsalate Therapy on Recovery From Vascular Injury in Female Zucker Fatty Rats
por: Murthy, Subramanyam N., et al.
Publicado: (2010)

Effect of Treatment with Salsalate, Menhaden Oil, Combination of Salsalate and Menhaden Oil, or Resolvin D1 of C57Bl/6J Type 1 Diabetic Mouse on Neuropathic Endpoints
por: Yorek, Matthew S., et al.
Publicado: (2016)

The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
por: Barzilay, Joshua I., et al.
Publicado: (2014)

Salsalate Attenuates Free Fatty Acid–Induced Microvascular and Metabolic Insulin Resistance in Humans
por: Chai, Weidong, et al.
Publicado: (2011)

Preparation and Characterization of Salsalate-Loaded Chitosan Nanoparticles: In Vitro Release and Antibacterial and Antibiofilm Activity
por: Ganesan, Sivarasan, et al.
Publicado: (2022)

Quantification of Cre-mediated recombination by a novel strategy reveals a stable extra-chromosomal deletion-circle in mice
por: Leonhard, Wouter N, et al.
Publicado: (2008)

High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease
por: Booij, Tijmen H., et al.
Publicado: (2017)

The effect of salsalate on biochemical factors and endothelial dysfunction of prediabetic patients: A randomized clinical trial
por: Fakhri, Maryam, et al.
Publicado: (2014)

Evaluating the efficacy of Salsalate on prediabetic and diabetic patients with fatty liver: A randomized clinical trial
por: Faghihimani, Elham, et al.
Publicado: (2013)

Salsalate Treatment Improves Glycemia Without Altering Adipose Tissue in Non-Diabetic Obese Hispanics
por: Alderete, Tanya L., et al.
Publicado: (2015)

Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model
por: Hüttl, Martina, et al.
Publicado: (2023)

Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD)
por: Goldfine, Allison B., et al.
Publicado: (2013)

Polycystic Kidney Disease Caused by Bilineal Inheritance of Truncating PKD1 as Well as PKD2 Mutations
por: Losekoot, Monique, et al.
Publicado: (2020)

Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients
por: Dekker, Shosha E.I., et al.
Publicado: (2022)

In vitro 3D phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease
por: Booij, Tijmen H, et al.
Publicado: (2019)

Salsalate Activates Skeletal Muscle Thermogenesis and Protects Mice from High-Fat Diet Induced Metabolic Dysfunction
por: Nie, Li, et al.
Publicado: (2017)

Salsalate Prevents β-Cell Dedifferentiation in OLETF Rats with Type 2 Diabetes through Notch1 Pathway
por: Han, Fei, et al.
Publicado: (2019)

Preventive Role of Salsalate in Diabetes Is Associated With Reducing Intestinal Inflammation Through Improvement of Gut Dysbiosis in ZDF Rats
por: Zhang, Xinrong, et al.
Publicado: (2020)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Effect of Salsalate on Insulin Action, Secretion, and Clearance in Nondiabetic, Insulin-Resistant Individuals: A Randomized, Placebo-Controlled Study
por: Kim, Sun H., et al.
Publicado: (2014)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Cardiometabolic risks and atherosclerotic disease in ApoE knockout mice: Effect of spinal cord injury and Salsalate anti-inflammatory pharmacotherapy
por: Bigford, Gregory E., et al.
Publicado: (2021)

Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles
por: Malas, Tareq B., et al.
Publicado: (2019)

Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1α Pathway
por: Jung, Tae Woo, et al.
Publicado: (2013)

Glomerular clusterin expression is increased in diabetic nephropathy and protects against oxidative stress-induced apoptosis in podocytes
por: He, Junling, et al.
Publicado: (2020)

Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease
por: Gerrits, Tessa, et al.
Publicado: (2022)

A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease
por: Cai, Jing, et al.
Publicado: (2018)

Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats
por: Davidson, Eric P., et al.
Publicado: (2018)

Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls
por: Trnovská, Jaroslava, et al.
Publicado: (2017)

Reducing YAP expression in Pkd1 mutant mice does not improve the cystic phenotype
por: Formica, Chiara, et al.
Publicado: (2020)

Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease
por: Rocchetti, Maria Teresa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2csajhokfj04pj9pc26r3jdvep